These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 24056206)

  • 1. Proteomics in uveal melanoma.
    Ramasamy P; Murphy CC; Clynes M; Horgan N; Moriarty P; Tiernan D; Beatty S; Kennedy S; Meleady P
    Exp Eye Res; 2014 Jan; 118():1-12. PubMed ID: 24056206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of fourteen proteins between uveal melanoma from patients who subsequently developed distant metastases versus those who did Not.
    Linge A; Kennedy S; O'Flynn D; Beatty S; Moriarty P; Henry M; Clynes M; Larkin A; Meleady P
    Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4634-43. PubMed ID: 22570344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomics in uveal melanoma research: opportunities and challenges in biomarker discovery.
    Pardo M; Dwek RA; Zitzmann N
    Expert Rev Proteomics; 2007 Apr; 4(2):273-86. PubMed ID: 17425462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomics of uveal melanomas suggests HSP-27 as a possible surrogate marker of chromosome 3 loss.
    Coupland SE; Vorum H; Mandal N; Kalirai H; Honoré B; Urbak SF; Lake SL; Dopierala J; Damato B
    Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):12-20. PubMed ID: 19643972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. iTRAQ Quantitative Proteomic Comparison of Metastatic and Non-Metastatic Uveal Melanoma Tumors.
    Crabb JW; Hu B; Crabb JS; Triozzi P; Saunthararajah Y; Tubbs R; Singh AD
    PLoS One; 2015; 10(8):e0135543. PubMed ID: 26305875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor-1 receptor in uveal melanoma: a predictor for metastatic disease and a potential therapeutic target.
    All-Ericsson C; Girnita L; Seregard S; Bartolazzi A; Jager MJ; Larsson O
    Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):1-8. PubMed ID: 11773005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinase-2 (MMP-2) immunoreactive protein--a new prognostic marker in uveal melanoma?
    Väisänen A; Kallioinen M; von Dickhoff K; Laatikainen L; Höyhtyä M; Turpeenniemi-Hujanen T
    J Pathol; 1999 May; 188(1):56-62. PubMed ID: 10398141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemokine receptor CCR7 expression predicts poor outcome in uveal melanoma and relates to liver metastasis whereas expression of CXCR4 is not of clinical relevance.
    van den Bosch T; Koopmans AE; Vaarwater J; van den Berg M; de Klein A; Verdijk RM
    Invest Ophthalmol Vis Sci; 2013 Nov; 54(12):7354-61. PubMed ID: 24052640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-depth proteomic profiling of the uveal melanoma secretome.
    Angi M; Kalirai H; Prendergast S; Simpson D; Hammond DE; Madigan MC; Beynon RJ; Coupland SE
    Oncotarget; 2016 Aug; 7(31):49623-49635. PubMed ID: 27391064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic analysis of uveal melanoma reveals novel potential markers involved in tumor progression.
    Zuidervaart W; Hensbergen PJ; Wong MC; Deelder AM; Tensen CP; Jager MJ; Gruis NA
    Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):786-93. PubMed ID: 16505008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the metastasis suppressor gene KISS1 in uveal melanoma.
    Martins CM; Fernandes BF; Antecka E; Di Cesare S; Mansure JJ; Marshall JC; Burnier MN
    Eye (Lond); 2008 May; 22(5):707-11. PubMed ID: 18219339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating tumor cells in uveal melanoma.
    Torres V; Triozzi P; Eng C; Tubbs R; Schoenfiled L; Crabb JW; Saunthararajah Y; Singh AD
    Future Oncol; 2011 Jan; 7(1):101-9. PubMed ID: 21174541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic implications of the emerging molecular biology of uveal melanoma.
    Patel M; Smyth E; Chapman PB; Wolchok JD; Schwartz GK; Abramson DH; Carvajal RD
    Clin Cancer Res; 2011 Apr; 17(8):2087-100. PubMed ID: 21444680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible implications of MCAM expression in metastasis and non-metastatic of primary uveal melanoma patients.
    Beutel J; Wegner J; Wegner R; Ziemssen F; Nassar K; Rohrbach JM; Hilgers RD; Lüke M; Grisanti S
    Curr Eye Res; 2009 Nov; 34(11):1004-9. PubMed ID: 19958117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melanocortin 1 receptor is expressed by uveal malignant melanoma and can be considered a new target for diagnosis and immunotherapy.
    López MN; Pereda C; Ramírez M; Mendoza-Naranjo A; Serrano A; Ferreira A; Poblete R; Kalergis AM; Kiessling R; Salazar-Onfray F
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1219-27. PubMed ID: 17325166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and distribution of MMPs and TIMPs in human uveal melanoma.
    Lai K; Conway RM; Crouch R; Jager MJ; Madigan MC
    Exp Eye Res; 2008 Jun; 86(6):936-41. PubMed ID: 18423620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted therapy for uveal melanoma.
    Triozzi PL; Eng C; Singh AD
    Cancer Treat Rev; 2008 May; 34(3):247-58. PubMed ID: 18226859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human leukocyte antigen class I expression. Marker of poor prognosis in uveal melanoma.
    Blom DJ; Luyten GP; Mooy C; Kerkvliet S; Zwinderman AH; Jager MJ
    Invest Ophthalmol Vis Sci; 1997 Aug; 38(9):1865-72. PubMed ID: 9286277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical, pathologic, and imaging features and biological markers of uveal melanoma.
    Rashid AB; Grossniklaus HE
    Methods Mol Biol; 2014; 1102():397-425. PubMed ID: 24258990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology and management of uveal melanoma.
    Yonekawa Y; Kim IK
    Hematol Oncol Clin North Am; 2012 Dec; 26(6):1169-84. PubMed ID: 23116575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.